EUVIMEDEUVIMED entdecken
Open Access

Exploring the therapeutic potential of precision T-Cell Receptors (TCRs) in targeting KRAS G12D cancer through in vitro development

Weitao Zheng, Dong Jiang, Songen Chen, Meiling Wu, Baoqi Yan, Jiahui Zhai, Yunqiang Shi, Bin Xie, Xingwang Xie, Kanghong Hu, Wenxue Ma

Oncology Research · 2024

DOI: 10.32604/or.2024.056565 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2024. Verfasst von Weitao Zheng und 10 weiteren Autor:innen. Beteiligte Einrichtung: Sino-German Biomedical Center, National "111" Center for Cellular Regulation and Molecular Pharmaceutics, Cooperative Innovation Center of Industrial…. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins p21(ras), Receptors, Antigen, T-Cell, Mutation, Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins p21(ras)Receptors, Antigen, T-CellMutationNeoplasmsHumansCell Line, TumorLymphocytes, Tumor-InfiltratingImmunotherapy

Stichwörter der Autor:innen

AlloreactivityG12DKirsten rat sarcoma virus (KRAS)T cell receptor (TCR)TCR therapyTumor-infiltrating lymphocytes (TILs)

Substanzen

Proto-Oncogene Proteins p21(ras)KRAS protein, humanReceptors, Antigen, T-Cell

Autor:innen und Institutionen

  • Sino-German Biomedical Center, National "111" Center for Cellular Regulation and Molecular Pharmaceutics, Cooperative Innovation Center of Industrial Fermentation (Ministry of Education of China & Hubei Province), Hubei…
  • Center of Research & Development, Beijing CorreGene Biotechnology Co., Ltd., Beijing, 102206, China.
  • Department of Medicine, Sanford Stem Cell Institute and Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.

Zitieren

APA

Zheng, W., Jiang, D., Chen, S., Wu, M., Yan, B., Zhai, J., Shi, Y., Xie, B., Xie, X., Hu, K., & Ma, W. (2024). Exploring the therapeutic potential of precision T-Cell Receptors (TCRs) in targeting KRAS G12D cancer through in vitro development. Oncology Research. https://doi.org/10.32604/or.2024.056565

Vancouver

Zheng W, Jiang D, Chen S, Wu M, Yan B, Zhai J, et al. Exploring the therapeutic potential of precision T-Cell Receptors (TCRs) in targeting KRAS G12D cancer through in vitro development. Oncology Research. 2024. doi:10.32604/or.2024.056565

BibTeX
@article{Zheng2024,
  author = {Zheng, Weitao and Jiang, Dong and Chen, Songen and Wu, Meiling and Yan, Baoqi and Zhai, Jiahui and Shi, Yunqiang and Xie, Bin and Xie, Xingwang and Hu, Kanghong and Ma, Wenxue},
  title = {Exploring the therapeutic potential of precision T-Cell Receptors (TCRs) in targeting KRAS G12D cancer through in vitro development},
  journal = {Oncology Research},
  year = {2024},
  doi = {10.32604/or.2024.056565}
}
Kostenlos starten →